| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | Eduardo Gotuzzo | Q29997973 |
| Angelica Terashima | Q29997979 | ||
| José Antonio Pérez-Molina | Q52733843 | ||
| Cesar Henriquez-Camacho | Q56868252 | ||
| Maria N Plana | Q56868264 | ||
| P2093 | author name string | Frine Samalvides | |
| Juan Echevarria | |||
| A Clinton White Jr | |||
| P2860 | cites work | Letter: Treatment of strongyloidiasis | Q67325025 |
| [Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis] | Q68012214 | ||
| A clinical trial of thiabendazole in strongyloidiasis | Q68583148 | ||
| Treatment of strongyloides stercoralis with albendazole. A cure rate of 86 per cent | Q69101881 | ||
| [Comparative study of thiabendazole and mebendazole in strongyloidiasis] | Q69656401 | ||
| Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness | Q70359052 | ||
| Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum | Q70597431 | ||
| The treatment of chronic strongyloidiasis with thiabendazole | Q72370808 | ||
| Three- to 7-year follow-up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease) | Q72765661 | ||
| The global programme to eliminate lymphatic filariasis: health impact after 8 years | Q21092299 | ||
| Severe strongyloidiasis: a systematic review of case reports | Q21261808 | ||
| Ivermectin versus benzimidazoles for treating strongyloides infection | Q24197775 | ||
| Strongyloides stercoralis: there but not seen | Q24596513 | ||
| Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm | Q28238731 | ||
| Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections | Q28473703 | ||
| Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial | Q28473776 | ||
| Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis | Q28479270 | ||
| Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies | Q31444212 | ||
| Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis | Q33900291 | ||
| Strongyloidiasis--progress in diagnosis and treatment | Q34021710 | ||
| Albendazole: a review of anthelmintic efficacy and safety in humans | Q34269976 | ||
| Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations. | Q34324579 | ||
| Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population | Q34349310 | ||
| Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis | Q34372239 | ||
| Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal | Q34431565 | ||
| The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. | Q34563642 | ||
| Ivermectin, 'wonder drug' from Japan: the human use perspective | Q34598257 | ||
| Seroepidemiology of strongyloidiasis in the Peruvian Amazon. | Q34700797 | ||
| Strongyloides stercoralis: a plea for action | Q34723461 | ||
| Antiparasitic drugs | Q34732838 | ||
| Strongyloides stercoralis: Global Distribution and Risk Factors | Q34855113 | ||
| Strongyloides stercoralis in the Immunocompromised Population | Q35545577 | ||
| A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection | Q36045375 | ||
| Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis | Q36199164 | ||
| Ivermectin 20 years on: maturation of a wonder drug | Q36242572 | ||
| Ivermectin for human strongyloidiasis and other intestinal helminths | Q36418225 | ||
| Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review | Q36419814 | ||
| Ivermectin as an antiparasitic agent for use in humans | Q36784620 | ||
| Strongyloides hyperinfection syndrome after intestinal transplantation | Q36867440 | ||
| Experimental Infection of Human Subjects with Strongyloides Species | Q36924068 | ||
| Reproduction in Strongyloides (Nematoda): a life between sex and parthenogenesis | Q37031005 | ||
| Rapid re-infection with soil-transmitted helminths after triple-dose albendazole treatment of school-aged children in Yunnan, People's Republic of China | Q37107970 | ||
| Molecular diagnostics of intestinal parasites in returning travellers. | Q37378256 | ||
| Strongyloidiasis--the most neglected of the neglected tropical diseases? | Q37425812 | ||
| Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection. | Q37473403 | ||
| Effects of maternal worm infections and anthelminthic treatment during pregnancy on infant motor and neurocognitive functioning | Q37627668 | ||
| Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view | Q37628190 | ||
| Acute strongyloidiasis in Italian tourists returning from Southeast Asia | Q38875886 | ||
| Albendazole is effective treatment for chronic strongyloidiasis | Q38878887 | ||
| Imported strongyloidiasis: epidemiology, presentations, and treatment. | Q38925853 | ||
| Repeated doses of albendazole against strongyloidiasis in Thai children | Q38938764 | ||
| A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children | Q39218165 | ||
| Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole | Q39308456 | ||
| Imported strongyloidosis: a longitudinal analysis of 31 cases | Q39311778 | ||
| Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis | Q39327559 | ||
| A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. | Q39358733 | ||
| Albendazole in the treatment of strongyloidiasis. | Q39371431 | ||
| Ivermectin in human medicine | Q40564978 | ||
| Strongyloidiasis in patients with hematologic malignancies | Q40680715 | ||
| Disseminated strongyloidiasis in a diabetic patient. | Q40778447 | ||
| Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans | Q41892096 | ||
| Use of antiprotozoan and anthelmintic drugs during pregnancy: side-effects and contra-indications | Q43819549 | ||
| Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study | Q44007167 | ||
| Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis | Q44226268 | ||
| Case report: Rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. | Q44326044 | ||
| Prevalence of intestinal nematodes in alcoholic patients | Q44337673 | ||
| A field study of the effect of ivermectin on intestinal helminths in man. | Q44585431 | ||
| New trial with thiabendazole for treatment of human strongyloidiasis | Q44971380 | ||
| Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole | Q45001853 | ||
| Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. | Q45037592 | ||
| Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection | Q45419895 | ||
| Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies). | Q45646188 | ||
| Ivermectin-derived leishmanicidal compounds | Q46180272 | ||
| Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee | Q46745205 | ||
| Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru | Q46839770 | ||
| Mode of action of benzimidazoles | Q47969579 | ||
| Strongyloides hyperinfection: a treatment dilemma. | Q50773354 | ||
| Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. | Q50904249 | ||
| Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis | Q52442474 | ||
| Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. | Q52541880 | ||
| [Clinical study on ivermectin against 125 strongyloidiasis patients]. | Q52543242 | ||
| A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. | Q52543470 | ||
| Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. | Q52583185 | ||
| Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. | Q52657961 | ||
| Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. | Q52659015 | ||
| Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. | Q52659363 | ||
| Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. | Q55239520 | ||
| [Clinical study of albendazole therapy for strongyloidiasis]. | Q55241556 | ||
| Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis | Q64128587 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 | ||
| Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Strongyloides stercoralis | Q244111 |
| albendazol | Q411629 | ||
| ivermectin | Q415178 | ||
| thiabendazole | Q424986 | ||
| anthelmintic | Q572294 | ||
| strongyloidiasis | Q2360849 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | CD007745 | |
| P577 | publication date | 2016-01-18 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection |
| Q48501088 | Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection-A systematic review and meta-analysis |
| Q57144462 | Argument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease List |
| Q47400439 | Case Report: Strongyloides stercoralis Hyperinfection in a Patient with Chronic Lymphocytic Leukemia |
| Q89855319 | Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017 |
| Q92134645 | Clinico-epidemiological spectrum of strongyloidiasis in India: Review of 166 cases |
| Q91716521 | Co-infection with Strongyloides stercoralis hyperinfection syndrome and Klebsiella in a nephrotic syndrome patient: A case report |
| Q98946636 | Descriptive Investigation of Strongyloidiasis Infection and Characterization of Strongyloides stercoralis Using Morphological and Molecular-Based Methods |
| Q49195473 | Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). |
| Q89539711 | Donor-derived fatal hyperinfection strongyloidiasis in renal transplant recipient |
| Q60468317 | Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review |
| Q52558340 | Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review meta-analysis and individual patient data analysis. |
| Q39393623 | Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries. |
| Q55248153 | Fatal pancytopenia due to albendazole treatment for strongyloidiasis. |
| Q54058578 | Helminths in organ transplantation. |
| Q64231806 | Hemoptysis in the Immunocompromised Patient: Do Not Forget Strongyloidiasis |
| Q40674060 | Human infection with Strongyloides stercoralis and other related Strongyloides species |
| Q55555554 | Immunosuppression with Antitumour Necrosis Factor Therapy Leading to Strongyloides Hyperinfection Syndrome. |
| Q64905240 | Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017). |
| Q54267770 | Management of severe strongyloidiasis attended at reference centers in Spain. |
| Q33921954 | Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome |
| Q33762384 | Prevalence and Correlates of Intestinal Parasites among Patients Admitted to Mirembe National Mental Health Hospital, Dodoma, Tanzania |
| Q38964382 | Prevalence of Strongyloides stercoralis and Other Intestinal Parasite Infections in School Children in a Rural Area of Angola: A Cross-Sectional Study. |
| Q54221088 | Prevalence of Strongyloides stercoralis infection and other soil-transmitted helminths by cross-sectional survey in a rural community in Gisagara District, Southern Province, Rwanda. |
| Q40118366 | Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis |
| Q92300733 | Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017) |
| Q89467263 | Severe Strongyloides stercoralis infection in kidney transplant recipients: A multicenter case-control study |
| Q38672434 | Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania |
| Q36126507 | StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control |
| Q40516833 | Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection |
| Q40288927 | Strongyloides Hyperinfection in a Renal Transplant Patient: Always Be on the Lookout. |
| Q37745089 | Strongyloides Stercoralis Infection Among Human Immunodeficiency Virus (HIV)-Infected Patients in the United States of America: A Case Report and Review of Literature. |
| Q47718937 | Strongyloides stercoralis and hookworm co-infection: spatial distribution and determinants in Preah Vihear Province, Cambodia |
| Q46837198 | Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children |
| Q92901631 | Strongyloides stercoralis: Spatial distribution of a highly prevalent and ubiquitous soil-transmitted helminth in Cambodia |
| Q42396722 | Strongyloidiasis in the immunocompetent: an overlooked infection |
| Q90070207 | [Acute renal failure and rare severe complication of systemic steroid treatment in a 73-year-old woman] |
Search more.